These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 14572175

  • 1. A clinical decision and economic analysis model of cancer pain management.
    Abernethy AP, Samsa GP, Matchar DB.
    Am J Manag Care; 2003 Oct; 9(10):651-64. PubMed ID: 14572175
    [Abstract] [Full Text] [Related]

  • 2. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
    Kutikova L, Bowman L, Chang S, Long SR, Obasaju C, Crown WH.
    Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249
    [Abstract] [Full Text] [Related]

  • 3. The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making.
    Palmer AJ, Roze S, Valentine WJ, Minshall ME, Foos V, Lurati FM, Lammert M, Spinas GA.
    Curr Med Res Opin; 2004 Aug; 20 Suppl 1():S5-26. PubMed ID: 15324513
    [Abstract] [Full Text] [Related]

  • 4. Tissue plasminogen activator was cost-effective compared to streptokinase in only selected patients with acute myocardial infarction.
    Kent DM, Vijan S, Hayward RA, Griffith JL, Beshansky JR, Selker HP.
    J Clin Epidemiol; 2004 Aug; 57(8):843-52. PubMed ID: 15485737
    [Abstract] [Full Text] [Related]

  • 5. Cost-effectiveness of two self-care interventions to reduce disability associated with back pain.
    Strong LL, Von Korff M, Saunders K, Moore JE.
    Spine (Phila Pa 1976); 2006 Jul 01; 31(15):1639-45. PubMed ID: 16816756
    [Abstract] [Full Text] [Related]

  • 6. Improving pain & symptom management for advanced cancer patients with a clinical decision support system.
    Elvidge K.
    Stud Health Technol Inform; 2008 Jul 01; 136():169-74. PubMed ID: 18487726
    [Abstract] [Full Text] [Related]

  • 7. Cost of depression in Europe.
    Sobocki P, Jönsson B, Angst J, Rehnberg C.
    J Ment Health Policy Econ; 2006 Jun 01; 9(2):87-98. PubMed ID: 17007486
    [Abstract] [Full Text] [Related]

  • 8. A brief pain management program compared with physical therapy for low back pain: results from an economic analysis alongside a randomized clinical trial.
    Whitehurst DG, Lewis M, Yao GL, Bryan S, Raftery JP, Mullis R, Hay EM.
    Arthritis Rheum; 2007 Apr 15; 57(3):466-73. PubMed ID: 17394176
    [Abstract] [Full Text] [Related]

  • 9. A cost-effectiveness analysis of a peak flow-based asthma education and self-management plan in a high-cost population.
    de Asis ML, Greene R.
    J Asthma; 2004 Aug 15; 41(5):559-65. PubMed ID: 15360065
    [Abstract] [Full Text] [Related]

  • 10. Cost utility and budget impact of third-generation aromatase inhibitors for advanced breast cancer: a literature-based model analysis of costs in the Italian National Health Service.
    Marchetti M, Caruggi M, Colombo G.
    Clin Ther; 2004 Sep 15; 26(9):1546-61. PubMed ID: 15531017
    [Abstract] [Full Text] [Related]

  • 11. Cost-effectiveness of influenza vaccination in working-age cancer patients.
    Avritscher EB, Cooksley CD, Geraci JM, Bekele BN, Cantor SB, Rolston KV, Elting LS.
    Cancer; 2007 Jun 01; 109(11):2357-64. PubMed ID: 17457827
    [Abstract] [Full Text] [Related]

  • 12. Intraperitoneal cisplatin and paclitaxel versus intravenous carboplatin and paclitaxel chemotherapy for Stage III ovarian cancer: a cost-effectiveness analysis.
    Bristow RE, Santillan A, Salani R, Diaz-Montes TP, Giuntoli RL, Meisner BC, Armstrong DK, Frick KD.
    Gynecol Oncol; 2007 Sep 01; 106(3):476-81. PubMed ID: 17688927
    [Abstract] [Full Text] [Related]

  • 13. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ, Schrag D, Smith TJ, Mulvey TM, Langdon RM, Blum D, Ubel PA, Schnipper LE, American Society of Clinical Oncology.
    J Clin Oncol; 2009 Aug 10; 27(23):3868-74. PubMed ID: 19581533
    [Abstract] [Full Text] [Related]

  • 14. The costs of cancer to a major employer in the United States: a case-control analysis.
    Barnett A, Birnbaum H, Cremieux PY, Fendrick AM, Slavin M.
    Am J Manag Care; 2000 Nov 10; 6(11):1243-51. PubMed ID: 11185849
    [Abstract] [Full Text] [Related]

  • 15. Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States.
    Shepard CW, Ortega-Sanchez IR, Scott RD, Rosenstein NE, ABCs Team.
    Pediatrics; 2005 May 10; 115(5):1220-32. PubMed ID: 15867028
    [Abstract] [Full Text] [Related]

  • 16. The cost-effectiveness of infliximab (Remicade) in the treatment of ankylosing spondylitis in Canada.
    Kobelt G, Andlin-Sobocki P, Maksymowych WP.
    J Rheumatol; 2006 Apr 10; 33(4):732-40. PubMed ID: 16583476
    [Abstract] [Full Text] [Related]

  • 17. Determining the cost-effectiveness of a computer-based smoking cessation intervention in primary care.
    Smith MY, Cromwell J, DePue J, Spring B, Redd W, Unrod M.
    Manag Care; 2007 Jul 10; 16(7):48-55. PubMed ID: 17907712
    [Abstract] [Full Text] [Related]

  • 18. Evidence-based medicine is affordable: the cost-effectiveness of current compared with optimal treatment in rheumatoid and osteoarthritis.
    Andrews G, Simonella L, Lapsley H, Sanderson K, March L.
    J Rheumatol; 2006 Apr 10; 33(4):671-80. PubMed ID: 16541479
    [Abstract] [Full Text] [Related]

  • 19. Determining the cost of gastroesophageal reflux disease: a decision analytic model.
    Holzer SS, Juday TR, Joelsson B, Crawley JA.
    Am J Manag Care; 1998 Oct 10; 4(10):1450-60. PubMed ID: 10338737
    [Abstract] [Full Text] [Related]

  • 20. Health care in the 21st century: evidence-based medicine, patient preference-based quality, and cost effectiveness.
    Brown GC, Brown MM, Sharma S.
    Qual Manag Health Care; 2000 Oct 10; 9(1):23-31. PubMed ID: 11185879
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.